MAPK1 and lung carcinoma: The phenomenon of crosstalk between PI3K/AKT and MEK/ERK pathways was analyzed by using inhibitors of molecules of these signaling pathways alone or in combination with cisplatin in a panel of lung cancer-derived primary cell lines.